Media, Video 29 May 2023 VIDEO | Proactive Investors – May 2023 Orthocell’s MD Paul Anderson and John Van Der Wielen spoke with Andrew Scott at Proactive Investors about John's appointment as… Orthocell
Media, Video Orthocell’s Paul Anderson spoke with Andrew Scott at Proactive Investors to discuss to discuss the announcement that the Company had secured Device Technologies as the exclusive distribution partner for Remplirâ„¢ in the Australian marketplace. 08 Mar 2023 VIDEO | Proactive Investors – March 2023 Orthocell’s Paul Anderson spoke with Andrew Scott at Proactive Investors to discuss to discuss the announcement that the Company had… Orthocell
Media, Video 07 Sep 2022 VIDEO | Proactive Investors – September 2022 Orthocell’s Paul Anderson spoke with Andrew Scott at Proactive Investors to discuss to discuss the announcement that the Company had… Orthocell
Media, Video 07 Sep 2022 Orthocell appoints Device Technologies as distributor of its nerve repair device in Aus, NZ Orthocell's distribution deal with Device Technologies has been featured in The West Australian, in this news article by business reporter… Orthocell
Media, Video 22 Jul 2022 VIDEO | Proactive Investors – July 2022 Orthocell’s Paul Anderson spoke with Alisha Newell at Proactive Investors to discuss the Company’s strong position following the recently executed… Orthocell
Media, Video 08 Jul 2022 VIDEO | ShareCafe ‘Hidden Gems’ Webinar – July 2022 Orthocell CEO and Managing Director, Paul Anderson, recently participated in the ShareCafe Small Cap ‘Hidden Gems’ Webinar. Orthocell
Media, Video 12 May 2022 Remplirâ„¢ Channel 7 News feature Clinical trial participant Damian Hall was featured in a national news story by Channel 7 News Reporter, Alison Fan, to… Orthocell
Media, Video 22 Mar 2022 VIDEO | Proactive Investors – March 2022 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in… Orthocell
Media, Video 02 Sep 2021 Video | Proactive Investors – September 2021 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in… Orthocell
Media, Video 03 Aug 2021 Video | Proactive Investors – Orthocell highlights potential for CelGro in treatment of lymphedema Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGroâ„¢ with… Orthocell
